Risk score could lead to better diagnosis of the metabolic syndrome in children

June 24, 2012

Researchers have developed a new scoring system that may better identify adolescents with the metabolic syndrome, a group at increased risk of later developing Type 2 diabetes and heart disease. The study, to be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston, describes what the authors call "the first racial/ethnic-specific and sex-specific scoring system for the metabolic syndrome."

"Children with the metabolic syndrome have more than 11 times the odds of developing Type 2 diabetes within 30 years than do those without this cluster of medical abnormalities," said study co-author Mark DeBoer, MD, assistant professor at the University of Virginia, Charlottesville. "A diagnosis of the metabolic syndrome can trigger intervention in adolescents and perhaps lead to starting preventive medical therapy sooner in those at highest risk for future disease."

Current diagnostic criteria for the metabolic syndrome were designed for adults and do not consider race. Even diagnostic criteria modified for use in adolescents tend to miss some children who likely are at increased risk, especially male African Americans, DeBoer said. Black adults have higher rates of Type 2 diabetes and death due to heart disease than do whites, U.S. statistics show, but the metabolic syndrome is less likely to be diagnosed in black male youth. DeBoer and his research partner Matthew Gurka, PhD, of West Virginia University, Morgantown, studied whether the characteristics of the metabolic syndrome might vary for different racial and ethnic groups.

A diagnosis of the metabolic syndrome depends on an individual having abnormal values in at least three of its five components: a large waistline, high blood pressure, high blood sugar levels, high triglycerides (levels of fat in the blood) and low levels of high-density-lipoprotein (HDL), or "good," cholesterol. However, some adolescents may have values that are just shy of the cutoffs for each component. These adolescents do not receive the diagnosis but are still likely at risk for consequences of the metabolic syndrome in adulthood, DeBoer said.

The researchers aimed to address these deficiencies in the definition of the metabolic syndrome by creating a risk score that was "continuous" and could therefore help identify children along a spectrum of worsening findings. This score is a sum of numeric values for all five components.

In addition, the investigators evaluated whether this score differed between races and ethnicities, specifically blacks, whites and Hispanics. To do this, they used factor analysis, a statistical approach that looks for a "behind-the-scenes" factor that helps determine how certain measures group together. The research team used data from 4,174 people ages 12 to 19 years who participated in the National Health and Nutrition Examination Survey from 1999 to 2010.

Results showed that individual components of the metabolic syndrome did group together differently between racial-ethnic groups. Male blacks, for instance, were less likely than other racial groups to have low "good" cholesterol, but when they did, it was a more ominous sign of worsening metabolic syndrome, DeBoer said. The new scoring system diagnosed the metabolic syndrome in nearly 76 percent of male blacks versus only 42 percent using the current system.

DeBoer said the new scoring system did better than the usual system at predicting which adolescents had elevations in cardiovascular risk factors that are related to the metabolic syndrome but not part of its diagnosis. These included fasting insulin levels, uric acid and C-reactive protein, a marker of inflammation associated with cardiovascular risk.
-end-


The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.